NCT02382237
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +8 more
- Locations
-
- ICM Val d'Aurelle Montpellier, France
Clinical trial condition
Oesophageal Cancer
Explore clinical trials studying Oesophageal Cancer. Study availability and eligibility vary by location and protocol.
50 public trials
13 recruiting studies
Oesophageal Cancer trial results
NCT03185403
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Epidural Block, +9 more
- Locations
-
- CHRU , Hôpital Claude Huriez Lille, France
NCT00359645
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +21 more
- Locations
-
- Centre Hospitalier MONTPERRIN Aix-en-Provence, France
- CHIAB Annemasse Bonneville Annemasse, France
- Centre Hospitalier d'ARRAS Arras, France
- CHS de L'Yonne Auxerre, France
NCT01657175
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +11 more
- Locations
-
- Skåne University Hospital Lund, Sweden
NCT02526134
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +13 more
- Locations
-
- Institut Paoli-Calmettes Marseille, France
NCT01179074
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
- Locations
-
- Departments of Gastrointestinal surgery, Gastroenterology, Radiation Oncology, All India Institute of Medical Sciences New Delhi, National Capital Territory of Delhi, India
Active, Not Recruiting
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
NCT05143970
- Conditions
- Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +48 more
- Locations
-
- Institut Paoli Calmettes Marseille, France
Active, Not Recruiting
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
NCT05057013
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +80 more
- Locations
-
- Royal Marsden NHS Foundation Trust London, United Kingdom
- The Christie Hospital Manchester, United Kingdom
- Freeman Hospital, Newcastle Newcastle, United Kingdom
- Churchill Hospital Oxford, United Kingdom
Active, Not Recruiting
Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab
NCT03653052
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
- Locations
-
- Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
Active, Not Recruiting
Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors
NCT06302660
- Conditions
- Bacterial Overgrowth, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- Barking, Havering and Redbridge University Hospitals NHS Trust London, United Kingdom
- Imperial College Healthcare NHS Trust London, United Kingdom
- West Hertfordshire NHS Teaching Hospitals London, United Kingdom